Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma

The current study was performed to determine whether tumor mitotic rate (TMR) is a useful, independent prognostic factor in patients with localized cutaneous melanoma.

[1]  A. Cochran,et al.  The Classification of Malignant Melanoma, its Histological Reporting and Registration: A Revision of the 1972 Sydney Classification , 1986, Pathology.

[2]  H. Shaw,et al.  Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma , 2002, Cancer.

[3]  V. Tompkins.  Cutaneous melanoma: Ulceration as a prognostic sign , 1953, Cancer.

[4]  D. Massi,et al.  Thick cutaneous malignant melanoma: a reappraisal of prognostic factors , 2000, Melanoma research.

[5]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.

[6]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. O'connor,et al.  Mitotically active leiomyomas of the uterus. , 1990, Human pathology.

[8]  V. McGovern,et al.  Prognostic significance of the histological features of malignant melanoma , 1979, Histopathology.

[9]  Strother H. Walker,et al.  Estimation of the probability of an event as a function of several independent variables. , 1967, Biometrika.

[10]  C. Holman,et al.  Inter‐observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia , 1984, Histopathology.

[11]  P S Ellis,et al.  Mitosis counting--a need for reappraisal. , 1981, Human pathology.

[12]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[13]  N. Petersen,et al.  Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I. , 1962, British journal of plastic surgery.

[14]  R. MacKie,et al.  Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. , 1995, British Journal of Cancer.

[15]  Charles M. Balch,et al.  Predicting survival and recurrence in localized melanoma: A multivariate approach , 1992, World Journal of Surgery.

[16]  David R. Cox.  The analysis of binary data , 1970 .

[17]  D. Allred,et al.  Improved methods of estimating mitotic activity in solid tumors. , 1992, Human pathology.

[18]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[19]  A. Kopf,et al.  Prognostic index for malignant melanoma. , 1978, Cancer.

[20]  M. Berwick,et al.  Predicting five‐year outcome for patients with cutaneous melanoma in a population‐based study , 1996, Cancer.

[21]  W. Clark,et al.  The classification of malignant melanoma and its histologic reporting , 1973, Cancer.

[22]  A. Lippold,et al.  Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? , 1999, Cancer.

[23]  G. Plewig,et al.  Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients , 2001, Melanoma research.

[24]  R. Vollmer.  Malignant melanoma. A multivariate analysis of prognostic factors. , 1989, Pathology annual.

[25]  A. Kopf,et al.  Influence of gender on survival in patients with stage I malignant melanoma. , 1992, Journal of the American Academy of Dermatology.

[26]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.